From the Desk of Dr. Edwin C. Chapman, MD. – Oversight needed on payers’ use of AI in prior authorization | American Medical Association
When it comes to access to buprenorphine and doses greater than 24 mgs to combat synthetics like fentanyl, statistics show that Black men like those in DC and other urban settings have borne the brunt of this regulatory implementation error!ECC Edwin C. Chapman, MDPrivate PracticeWashington, DC